SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-369457
Filing Date
2017-12-14
Accepted
2017-12-14 16:03:05
Documents
68
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d499419d10q.htm 10-Q 844853
2 EXHIBIT 10.1 d499419dex101.htm EX-10.1 105067
3 EXHIBIT 10.2 d499419dex102.htm EX-10.2 64651
4 EXHIBIT 31.1 d499419dex311.htm EX-31.1 6865
5 EXHIBIT 31.2 d499419dex312.htm EX-31.2 6235
6 EXHIBIT 32.1 d499419dex321.htm EX-32.1 3920
7 EXHIBIT 32.2 d499419dex322.htm EX-32.2 3614
  Complete submission text file 0001193125-17-369457.txt   4969593

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT spro-20170930.xml EX-101.INS 745464
9 XBRL TAXONOMY EXTENSION SCHEMA spro-20170930.xsd EX-101.SCH 63405
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE spro-20170930_cal.xml EX-101.CAL 57801
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE spro-20170930_def.xml EX-101.DEF 281495
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20170930_lab.xml EX-101.LAB 454890
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20170930_pre.xml EX-101.PRE 356472
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 171256190
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences